AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 160 filers reported holding AKERO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $708,656 | +53.5% | 30,207 | +65.2% | 0.00% | – |
| Q1 2024 | $461,753 | -88.2% | 18,280 | -89.1% | 0.00% | -100.0% |
| Q4 2023 | $3,899,847 | -1.0% | 167,017 | +97.9% | 0.01% | -42.9% |
| Q2 2023 | $3,939,562 | -3.0% | 84,377 | -20.5% | 0.01% | -76.7% |
| Q1 2023 | $4,060,610 | -26.8% | 106,132 | +4.9% | 0.06% | -41.2% |
| Q4 2022 | $5,544,006 | -20.2% | 101,168 | -50.4% | 0.10% | -23.3% |
| Q3 2022 | $6,948,000 | – | 204,043 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 423,849 | $9,943,498 | 11.19% |
| Propel Bio Management, LLC | 327,752 | $7,689,062 | 4.99% |
| GENERAL ATLANTIC, L.P. | 5,233,989 | $122,789,382 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 625,087 | $14,664,541 | 3.46% |
| Yiheng Capital Management, L.P. | 1,434,179 | $33,645,839 | 2.71% |
| Redmile Group, LLC | 1,614,473 | $37,875,537 | 2.29% |
| Boxer Capital, LLC | 1,676,733 | $39,336,156 | 2.07% |
| RTW INVESTMENTS, LP | 5,431,985 | $127,434,368 | 1.97% |
| Logos Global Management LP | 800,000 | $18,768,000 | 1.52% |
| MPM BioImpact LLC | 385,990 | $9,055,325 | 1.41% |